Overview

Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis

Status:
Completed

Trial end date:
2014-08-01

Target enrollment:

Participant gender:

Summary

The investigators aim to investigate the safety and efficacy of peripheral blood monocyte for the treatment of patients with advanced liver cirrhosis.

Phase:

Phase 1

Details

Lead Sponsor:

Seoul National University Hospital

Treatments:

Lenograstim
Sargramostim